Mitchell Sinkler & Starr’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $273K | Hold |
|
|||||
|
2024
Q3 | $299K | Buy |
|
|||||
|
2024
Q2 | $212K | Buy |
|
|||||
|
2024
Q1 | $154K | Sell |
|
|||||
|
2023
Q4 | $672K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $495K | Sell |
|
|||||
|
2023
Q1 | $465K | Buy |
|
|||||
|
2022
Q4 | $456K | Buy |
|
|||||
|
2022
Q3 | $425K | Buy |
|
|||||
|
2022
Q2 | $349K | Sell |
|
|||||
|
2022
Q1 | $430K | Buy |
|
|||||
|
2021
Q4 | $462K | Sell |
|
|||||
|
2021
Q3 | $562K | Buy |
|
|||||
|
2021
Q2 | $561K | Buy |
|
|||||
|
2021
Q1 | $511K | Hold |
|
|||||
|
2020
Q4 | $531K | Hold |
|
|||||
|
2020
Q3 | $420K | Buy |
|
|||||
|
2020
Q2 | $396K | Hold |
|
|||||
|
2020
Q1 | $274K | Sell |
|
|||||
|
2019
Q4 | $394K | Hold |
|
|||||
|
2019
Q3 | $316K | Sell |
|
|||||
|
2019
Q2 | $596K | Buy |
|
|||||
|
2019
Q1 | $560K | Hold |
|
|||||
|
2018
Q4 | $444K | Buy |
|
|||||
|
2018
Q3 | $579K | Buy |
|
|||||
|
2018
Q2 | $504K | Buy |
|